Use of negative pressure wound therapy in the treatment of neonatal and pediatric wounds: a retrospective examination of clinical outcomes.
The clinical effectiveness of negative pressure wound therapy for the management of acute and chronic wounds is well documented in the adult population but information regarding its use in the pediatric population is limited. A retrospective, descriptive study was conducted to examine the clinical outcomes of using negative pressure wound therapy in the treatment of pediatric wounds. The medical records of 24 consecutive pediatric patients receiving negative pressure wound therapy were reviewed. Demographic data, wound etiology, time to closure, closure method, duration of negative pressure wound therapy, complications, dressing change frequency, dressing type used, and pressure settings were analyzed. All categorical variables in the dataset were summarized using frequency (count and percentages) and all continuous variables were summarized using median (minimum, maximum). The 24 pediatric patients (mean age 8.5 years [range 14 days to 18 years old]) had 24 wounds - 12 (50%) were infected at baseline. Sixteen patients had hypoalbuminemia and six had exposed hardware and bone in their wounds. Twenty-two wounds reached full closure in a median time of 10 days (range 2 to 45) following negative pressure wound therapy and flap closure (11), split-thickness skin graft (three), secondary (four), and primary (four) closure. Pressures used in this population ranged from 50 to 125 mm Hg and most wounds were covered with reticulated polyurethane foam. One patient developed a fistula during the course of negative pressure wound therapy. When coupled with appropriate systemic antibiotics, surgical debridement, and medical and nutritional optimization, in this population negative pressure wound therapy resulted in rapid granulation tissue and 92% successful wound closure. Future neonatal and pediatric negative pressure wound therapy usage registries and prospective studies are needed to provide a strong evidence base from which treatment decisions can be made in the management of these challenging cases, especially pertaining to the safety and efficacy of pressure settings, dressings, and interposing contact layer selection.
Baharestani
Mona Mylene
MM
Wound Healing, Long Island Jewish Medical Center, Schneider Children's Hospital, New Hyde Park, New York 11040, USA. mbahares@nshs.edu
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001458:Bandages; D002648:Child; D002675:Child, Preschool; D015400:Clinical Nursing Research; D003646:Debridement / Q000379:methods; D019317:Evidence-Based Medicine; D005260:Female; D006776:Hospitals, Pediatric; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D017283:Neonatal Nursing / Q000379:methods; D009518:New York; D010371:Pediatric Nursing / Q000379:methods; D011140:Polyurethanes / Q000627:therapeutic use; D012042:Registries; D012189:Retrospective Studies; D017592:Skin Care / Q000379:methods* / Q000451:nursing; D013396:Suction / Q000379:methods* / Q000451:nursing; D013997:Time Factors; D016896:Treatment Outcome; D014945:Wound Healing; D014947:Wounds and Injuries / Q000209:etiology / Q000628:therapy*
D000900:Anti-Bacterial Agents; D011140:Polyurethanes; C028279:polyurethane foam